The Prescriber最新文献

筛选
英文 中文
Faricimab for treating wet AMD and diabetic macular oedema 法利昔单抗治疗湿性黄斑变性和糖尿病性黄斑水肿
The Prescriber Pub Date : 2022-11-01 DOI: 10.1002/psb.2026
S. Chaplin
{"title":"Faricimab for treating wet AMD and diabetic macular oedema","authors":"S. Chaplin","doi":"10.1002/psb.2026","DOIUrl":"https://doi.org/10.1002/psb.2026","url":null,"abstract":"Faricimab (Vabysmo) is a bispecific antibody against angiopoietin‐2 and VEGF‐A for the treatment of adults with wet age‐related macular degeneration (AMD) and visual impairment due to diabetic macular oedema. This article discusses its administration, clinical trial outcomes and place in therapy.","PeriodicalId":88184,"journal":{"name":"The Prescriber","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"88595503","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Prescribing Skills Assessment 处方技能评估
The Prescriber Pub Date : 2022-11-01 DOI: 10.1002/psb.2024
{"title":"Prescribing Skills Assessment","authors":"","doi":"10.1002/psb.2024","DOIUrl":"https://doi.org/10.1002/psb.2024","url":null,"abstract":"","PeriodicalId":88184,"journal":{"name":"The Prescriber","volume":"17 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"83776466","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Emerging roles of sodium‐glucose co‐transporter inhibitors 钠-葡萄糖共转运蛋白抑制剂的新作用
The Prescriber Pub Date : 2022-10-01 DOI: 10.1002/psb.2014
A. Barton
{"title":"Emerging roles of sodium‐glucose co‐transporter inhibitors","authors":"A. Barton","doi":"10.1002/psb.2014","DOIUrl":"https://doi.org/10.1002/psb.2014","url":null,"abstract":"Originally introduced as antidiabetic agents, the use of sodium‐glucose co‐transporter protein (SGLT) inhibitors has now expanded to a wider range of indications, including heart failure and chronic kidney disease, following positive clinical trial outcomes. This article summarises the properties of SGLT inhibitors and the increasing evidence base for their use in many cardiovascular and renal conditions.","PeriodicalId":88184,"journal":{"name":"The Prescriber","volume":"99 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"86091449","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Updated guideline on managing depression in adults 成人抑郁症管理的最新指南
The Prescriber Pub Date : 2022-10-01 DOI: 10.1002/psb.2017
S. Chaplin
{"title":"Updated guideline on managing depression in adults","authors":"S. Chaplin","doi":"10.1002/psb.2017","DOIUrl":"https://doi.org/10.1002/psb.2017","url":null,"abstract":"NICE recently updated its guideline on the management of depression in adults (NG222). This article summarises the new guidance, which includes detailed recommendations on treatment options for new episodes of depression, preventing relapse, further‐line therapy, and managing chronic depressive symptoms.","PeriodicalId":88184,"journal":{"name":"The Prescriber","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"88469676","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Upping our game when documenting adverse reactions 在记录不良反应时提高了我们的水平
The Prescriber Pub Date : 2022-10-01 DOI: 10.1002/psb.2020
A. Thompson
{"title":"Upping our game when documenting adverse reactions","authors":"A. Thompson","doi":"10.1002/psb.2020","DOIUrl":"https://doi.org/10.1002/psb.2020","url":null,"abstract":"Healthcare professionals’ documentation of adverse drug reactions is sometimes suboptimal, but it is important to take time to detail the nature of these reactions and their timing and severity to ensure patients’ safety and trust in the healthcare system.","PeriodicalId":88184,"journal":{"name":"The Prescriber","volume":"292 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"77300088","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prescribing Skills Assessment 处方技能评估
The Prescriber Pub Date : 2022-10-01 DOI: 10.1002/psb.2015
{"title":"Prescribing Skills Assessment","authors":"","doi":"10.1002/psb.2015","DOIUrl":"https://doi.org/10.1002/psb.2015","url":null,"abstract":"","PeriodicalId":88184,"journal":{"name":"The Prescriber","volume":"62 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"77196317","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cenobamate for focal‐onset seizures in resistant epilepsy 辛奥巴马治疗顽固性癫痫的局灶性发作
The Prescriber Pub Date : 2022-10-01 DOI: 10.1002/psb.2018
S. Chaplin
{"title":"Cenobamate for focal‐onset seizures in resistant epilepsy","authors":"S. Chaplin","doi":"10.1002/psb.2018","DOIUrl":"https://doi.org/10.1002/psb.2018","url":null,"abstract":"Cenobamate (Ontozry) is a new antiseizure medicine for the adjunctive treatment of focal‐onset seizures with or without secondary generalisation in patients with drug‐resistant epilepsy. This article summarises its properties and place in therapy.","PeriodicalId":88184,"journal":{"name":"The Prescriber","volume":"153 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"75317048","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ponesimod for the treatment of relapsing multiple sclerosis Ponesimod治疗复发性多发性硬化症
The Prescriber Pub Date : 2022-10-01 DOI: 10.1002/psb.2019
S. Chaplin
{"title":"Ponesimod for the treatment of relapsing multiple sclerosis","authors":"S. Chaplin","doi":"10.1002/psb.2019","DOIUrl":"https://doi.org/10.1002/psb.2019","url":null,"abstract":"Ponesimod (Ponvory) is a new sphingosine 1‐phosphate receptor modulator for the treatment of adults with relapsing forms of multiple sclerosis (MS). This article discusses its mode of action, efficacy and adverse effects.","PeriodicalId":88184,"journal":{"name":"The Prescriber","volume":"95 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"87955575","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Neurological diseases: optimism for the future 神经系统疾病:对未来持乐观态度
The Prescriber Pub Date : 2022-10-01 DOI: 10.1002/psb.2013
{"title":"Neurological diseases: optimism for the future","authors":"","doi":"10.1002/psb.2013","DOIUrl":"https://doi.org/10.1002/psb.2013","url":null,"abstract":"","PeriodicalId":88184,"journal":{"name":"The Prescriber","volume":"11 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"74030121","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Autoimmune diseases: the immunological tightrope 自身免疫性疾病:免疫绳索
The Prescriber Pub Date : 2022-10-01 DOI: 10.1002/psb.2016
M. Greener
{"title":"Autoimmune diseases: the immunological tightrope","authors":"M. Greener","doi":"10.1002/psb.2016","DOIUrl":"https://doi.org/10.1002/psb.2016","url":null,"abstract":"Discriminating ‘self’ from ‘non‐self’ and avoiding autoimmune disease is a fine balancing act for the immune system. Recent research has increased our understanding of the underlying mechanisms that throw immunity off balance, raising the prospect of improved management and earlier diagnosis of autoimmune conditions.","PeriodicalId":88184,"journal":{"name":"The Prescriber","volume":"43 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"87303904","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信